Targeting Cancer

OncoCell’s Subtraction Normalized Expression of Phagocytes (SNEP) RNA-based blood Assay can stratify patients with aggressive prostate cancer that need life-saving treatments from those with indolent prostate disease.  As a result, our SNEP immunogenomic blood test will substantially reduce the number of unnecessary, invasive, risky, and expensive prostate biopsies in men with a clinical suspicion of prostate cancer, improve their outcomes, and lead to significant cost savings for the U.S. healthcare system.